 | Up a level |
Arora, S; Andreassen, A K; Andersson, B; Gustafsson, F; Eiskjaer, H; Bøtker, H E; Rådegran, G; Gude, E; Ioanes, D; Solbu, D; Sigurdardottir, Vilborg; Dellgren, G; Erikstad, I; Solberg, O G; Ueland, T; Aukrust, P; Gullestad, L (2015). The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial. American journal of transplantation, 15(7), pp. 1967-1975. Wiley-Blackwell 10.1111/ajt.13214
Andreassen, A K; Andersson, B; Gustafsson, F; Eiskjaer, H; Radegran, G; Gude, E; Jansson, K; Solbu, D; Sigurdardottir, Vilborg; Arora, S; Dellgren, G; Gullestad, L (2014). Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial. American journal of transplantation, 14(8), pp. 1828-1838. Wiley-Blackwell 10.1111/ajt.12809
Arora, S; Erikstad, I; Ueland, T; Sigurdardottir, V; Ekmehag, B; Jansson, K; Eiskjaer, H; Bøtker, H E; Mortensen, S-A; Saunamaki, K; Gude, E; Ragnarsson, A; Solbu, D; Aukrust, P; Gullestad, L (2012). Virtual histology assessment of cardiac allograft vasculopathy following introduction of everolimus--results of a multicenter trial. American journal of transplantation, 12(10), pp. 2700-9. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2012.04234.x
